• Connecting Asian Biotech Innovation with Global Partners: A Bayer Co.Lab Showcase

    Connecting Asian Biotech Innovation with Global Partners: A Bayer Co.Lab Showcase

    Please confirm your attendance for Bayer Co.Lab's "Connecting Asian Biotech Innovation with Global Partners" Showcase at RESI Boston 2026.

  • 🔬 Connecting Asian Biotech Innovation with Global Partners: A Bayer Co.Lab Showcase

    📅 Date & Time: Tuesday, September 22, 2:00 - 4:00pm EST

    📍 Location: The Westin Copley Place, 10 Huntington Ave, Boston, MA 02116

    As Title Sponsor of RESI Boston 2026, Bayer Co.Lab, Bayer’s global network of life science incubators supporting early-stage entrepreneurs and breakthrough innovation, is proud to host Connecting Asian Biotech Innovation with Global Partners: A Bayer Co.Lab Showcase.

    This 2-hour program will feature 7 emerging biotechnology companies from Korea and Japan, showcasing innovative therapeutic approaches across gene therapy, RNA therapeutics, exosome technologies, small molecules, and other next-generation platforms. 

    The showcase reflects Bayer Co.Lab’s commitment to fostering early-stage innovation and creating connections across global life science ecosystems. By bringing promising Korean and Japanese biotech companies to RESI Boston, the program aims to create new opportunities for international collaboration and connect emerging innovators with pharmaceutical partners, investors, and other strategic stakeholders.

    Investors, pharmaceutical and strategic partners, business development and licensing professionals, and other industry leaders interested in discovering emerging Asian biotech innovation and exploring potential collaboration opportunities are warmly invited to attend.

  • Are you already registered for RESI Boston 2026?*
  • Would you like to be registered for RESI Boston 2026?*
  • Please confirm your RSVP:*
    • ⬇️ Learn More About the 7 Pitching Companies 

    • artiCure | Korea
      Tumor-selective replicating gene therapy targeting solid tumors

      Crafton Biotechnology | Japan
      mRNA therapeutics supported by advanced computational approaches

      Curigin | Korea
      RNA-based therapeutic technologies across multiple disease areas

      Elisigen | Korea
      Next-generation gene therapy with programs in ophthalmology

      Genome & Company | Korea
      Microbiome-driven therapeutic discovery and development

      ILIAS Biologics | Korea
      Exosome-based therapeutics for inflammatory and fibrotic diseases

      Kanjin Therapeutics | Japan
      RNA therapeutics, including siRNA and antisense approaches, for areas of unmet medical need

    • ⬇️ Learn More About Bayer Co.Lab 

    •  

      Bayer Co.Lab is Bayer’s pioneering global network of life science incubators focused on disruptive innovation and scientific breakthroughs. With strategic locations in Cambridge, Berlin, Kobe, and Shanghai, Bayer Co.Lab brings together early-stage life science entrepreneurs with world-class expertise, resources, and global networks to help transform groundbreaking ideas into impactful healthcare solutions. The network seeks innovative technologies and creative approaches aligned with Bayer’s strategic research areas, while providing support to participating startups with no strings attached.

      Designed to reduce the financial and operational barriers facing emerging life science companies, Bayer Co.Lab provides access to state-of-the-art laboratory and office space, shared scientific equipment, and a dynamic community of fellow innovators. Startups can also benefit from tailored mentorship from Bayer experts around the globe, gaining access to scientific and industry expertise while remaining independent. Through its international network, Bayer Co.Lab helps foster connections between entrepreneurs and leading life science innovation ecosystems around the world.

      By combining cutting-edge infrastructure, expert mentorship, and opportunities for global connectivity, Bayer Co.Lab creates an environment where visionary early-stage companies can focus on advancing their science, generating data, and developing the next generation of healthcare solutions.

      >> For more information, please visit https://colab.bayer.com.

    • Should be Empty: